American women are spending less out of pocket for birth control, with more savings on the horizon.» Read More
Aetna and Humana announce a record-setting $37 billion deal.
As sports grapples with the effects of injuries, one area of medicine is looking to make pain and recovery a thing of the past.
The case revolves around subsidies that help reduce out-of-pocket costs for most Obamacare customers.
U.S. health insurer Aetna is close to buying rival Humana and a deal could be signed as early as this weekend, Bloomberg reported.
Despite losing in court, Obamacare critics said the law still has deep flaws.
Deal fever appears to have overtaken the health insurers. And Obamacare may be part of the reason why.
Nearly 75 percent percent of Humana’s revenue comes from Medicare, more than the other big insurers. Here's why Humana is such a hot commodity.
Athena Health CEO Jonathan Bush said that more talks of M&A in health care are just a reflection of slowing innovation in the industry.
Some Oregon insurers want to keep their health plan premium increases moderate for next year, but the state wants them higher.
California's health insurance exchange will collect health insurance data on its 1.4 million customers.
Sachin Shah, special situations and merger arbitrage strategist at Albert Fried and Company, attributes the flurry of M&A activities in the health insurer space to the implementation of Obamacare.
Raghuram Selvaraju, managing director of Equity Research and Healthcare at MLV & Co, discusses news that Cigna has rejected a $47.5 billion takeover offer from Anthem.
Cigna on Sunday rejected an increased $53.8 billion bid from Anthem as inadequate.
Anthem renewed its bid for Cigna, upping its original offer to $184 per share in a deal valued at nearly $53.8 billion.
The extra money comes as some insurers proposed double-digit premium increases for 2016 amid concerns about higher costs.
Consolidation in the health insurance industry is "potentially dangerous" for the hospital business, Mount Sinai Health System's CEO said Thursday.
Some think it is unlikely that a round of consolidation in the health insurance industry will push prices higher for consumers.
Americans place controlling drug costs at the top of their health-related concerns.
Most HealthCare.gov states are not expected to act quickly enough to maintain Obamacare subsidies if the Supreme Court ends them.
Rates, if approved, would rise average of 12 percent in many major cities, and more for the most popular plans.
Get the best of CNBC in your inbox